Expertise in
8
conditions

Fernando Pico

Paris, FR 
Expertise in
8
conditions
Paris, FR 
OverviewLocationsClinical Research

Overview

Fernando Pico practices in Paris, France. Mr. Pico is highly rated in 8 conditions, according to our data. His top areas of expertise are Ethmoiditis, Stroke, Transient Ischemic Attack (TIA), Thrombectomy, and Craniectomy.

His clinical research consists of co-authoring 84 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Paris, France
Other Locations
Versailles, France
Le Chesnay, France
Gif-sur-yvette, France
Caen, France
Saint-quentin-le-verger, France
Argenteuil, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes
Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes
Enrollment Status: Active_not_recruiting
Publish Date: August 21, 2024
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Biological, Drug, Other
Study Drugs: Vitamin D, Lumbar Puncture, Blood Sampling, Urine Samples
Study Phase: Phase 3
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Enrollment Status: Terminated
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

84 Total Publications

Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy.
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy.
Journal: JAMA neurology
Published: December 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pico's expertise for a condition
ConditionClose
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile